COFG Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
COFG Advisors's BMY Position: Q2 2026 in Review
COFG Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.9% in Q2 2026, buying an estimated $6.78K and bringing the position to 4,247 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #278.
COFG Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $250K in Q1 2026. 2,399 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- COFG Advisors held 4,247 shares of Bristol-Myers Squibb worth $245K as of Q2 2026.
- COFG Advisors bought 118 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.78K.
- Bristol-Myers Squibb made up 0.04% of COFG Advisors's portfolio in Q2 2026, its #278 holding.
- COFG Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- COFG Advisors's Bristol-Myers Squibb position peaked at $250K in Q1 2026.
- 2,399 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on COFG Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.